Search results
Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed...
Pharmaceutical Executive Magazine· 5 days agoResults from the IMROZ Phase III trial show that Sanofi’s Sarclisa (isatuximab-irfc) in combination...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com
Investing.com· 6 days agoAnalysts indicated that GSK's potential liability from the litigation could exceed the $2 billion to...
3 Dividend Stocks to Buy in June 2024 for Dependable Dividend Growth
InvestorPlace· 6 days agoInvesting in dividend growth stocks is a popular strategy for those seeking a dependable income...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 6 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters· 6 days agoShares of British drugmaker GSK dropped more than 9% on Monday, after a Delaware judge allowed more...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 3 days agoRecent news, though, has set Novavax stock on a sprint. Shares skyrocketed more than 125% on May 10...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 6 days agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
The chicken and egg problem of fighting another flu pandemic
Oregon Capital Chronicle via Yahoo News· 1 day agoEven a peep of news about a new flu pandemic is enough to set scientists clucking about eggs. They...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters via AOL· 6 days agoFollowing the ruling, analysts at J.P. Morgan said the potential liability that GSK could face from...
FDLI’s Top Cases 2024 Featuring Partner Andrew Wasson | JD Supra
JD Supra· 2 days agoPartner Andrew Wasson contributed a chapter to the Food & Drug Law Institute’s annual publication identifying the top food and drug cases of the year. Amgen v. Sanofi is undeniably ...